Literature DB >> 10954

Closing remarks: current status of labetalol.

C T Dollery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10954

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

Review 1.  Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

2.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

3.  Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.

Authors:  M Aggerbeck; G Guellaen; J Hanoune
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

4.  Improved deep controlled hypotension in aneurysmal surgery.

Authors:  V Lüben; G Hempelmann
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

5.  Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.

Authors:  B N Prichard; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

6.  [Acute combined alpha- and beta-adrenergic blockade in essential hypertension: effects on blood pressure, renal function, renin, and aldosterone].

Authors:  U Grüninger; R Akert; H Hunkeler; E Wegmüller; P Weidmann; J Hodler
Journal:  Klin Wochenschr       Date:  1979-07-15

Review 7.  Clinical pharmacokinetics of labetalol.

Authors:  J J McNeil; W J Louis
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 8.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546

9.  Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.

Authors:  E M Besterman; M Spencer
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

10.  A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.

Authors:  A G Chalmers; J Hunter; C D Lees; J A Millar; J J Brown; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.